Drug details

Linzess (linaclotide capsules)

type of IBS Agents, Gastrointestinals, Guanylate Cyclase-C Agonists

Linzess (linaclotide) is a guanylate cyclase-C agonist indicated for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, chronic idiopathic constipation (CIC) in adults, and functional constipation (FC) in pediatric patients 6 to 17 years of age.

This drug may have the following side effects:

• diarrhea,
• headache, and
• abdominal pain,
• gas,
• bloating,
• viral gastroenteritis.

The following drugs are related to Linzess, either as a replacement or used together:

• Lotronex (alosetron hydrochloride)
• Alosetron Hydrochloride Tablets (alosetron hydrochloride)
• Bentyl (dicyclomine)
• Librax (chlordiazepoxide and clidinium)
• Constulose (lactulose solution, usp 10 g/15 ml)
• Ibsrela (tenapanor tablets)
• Kristalose (kristalose lactulose oral solution)
• Pizensy (lactitol tablets)
• Motegrity (prucalopride tablets)
• Trulance (plecanatide tablets)
• Zelnorm (tegaserod maleate)